ACB

Aurora Cannabis

4.31 USD
+0.04
0.94%
At close Dec 13, 4:00 PM EST
After hours
4.27
-0.04
0.93%
1 day
0.94%
5 days
-4.43%
1 month
-5.07%
3 months
-25.69%
6 months
-26.95%
Year to date
-9.26%
1 year
-10.21%
5 years
-98.63%
10 years
-99.53%
 

About: Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

Employees: 1,130

0
Funds holding %
of 6,805 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

78% more call options, than puts

Call options by funds: $47.2M | Put options by funds: $26.5M

15% more capital invested

Capital invested by funds: $18.4M [Q2] → $21.1M (+$2.79M) [Q3]

0.71% less ownership

Funds ownership: 7.29% [Q2] → 6.58% (-0.71%) [Q3]

12% less funds holding

Funds holding: 162 [Q2] → 142 (-20) [Q3]

18% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 34

59% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 34

Research analyst outlook

We haven’t received any recent analyst ratings for ACB.

Financial journalist opinion

Based on 7 articles about ACB published over the past 30 days

Negative
Benzinga
2 weeks ago
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
Cannabis stocks have faced significant challenges recently, driven by political uncertainty that has further weighed on a sector still struggling to regain its footing since the overhyped all-time highs of 2021.
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
Neutral
PRNewsWire
2 weeks ago
Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Continues to Offer Greater Choice for Patients EDMONTON, AB , Nov. 26, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces developments in cannabis science from Aurora's world class research and genetics facility, Aurora Coast. With a continued focus on premium, science-driven insights, these latest innovations demonstrate Aurora's commitment to providing patients with ongoing access to superior product offerings on AuroraMedical.com.
Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility
Negative
WSJ
3 weeks ago
Marijuana Industry Could Stay in Limbo Under Trump
A hands-off policy on cannabis will be a bad outcome for a business already struggling with ambiguous laws.
Marijuana Industry Could Stay in Limbo Under Trump
Neutral
PRNewsWire
3 weeks ago
Aurora Cannabis Expands Innovative Recreational Product Portfolio
NASDAQ | TSX: ACB Introduces New Products and Flavours across Greybeard, San Rafael '71 and Tasty's brands EDMONTON, AB , Nov. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is excited to announce its latest lineup of innovations from Greybeard, San Rafael '71 and Tasty's brands. With a continued focus on premium, science-driven offerings, this expanded lineup represents Aurora's commitment to delivering exceptional high quality, cutting-edge and diverse options for Canadian cannabis consumers.
Aurora Cannabis Expands Innovative Recreational Product Portfolio
Positive
Seeking Alpha
4 weeks ago
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks from the past week, aiming to spark ideas and discussions among retail investors. Veradigm Inc. is undervalued due to regulatory pressures, but has significant upside potential with strategic buyers potentially paying mid- or high-teens per share. Casey's General Stores has outperformed its peers and the S&P 500 due to its strategic positioning in rural areas and strong operational execution.
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +
Positive
MarijuanaStocks
4 weeks ago
3 Marijuana Stocks For Today Watchlist
The future of cannabis investing rests in the hands of politicians who may not have the industry's best interests at heart. Right now, the majority of marijuana stocks are feeling the impact of cannabis politics surrounding reform and regulatory issues. Each party, Republicans and Democrats, walks a different path to passing comprehensive reform and looking at the sector as a whole.
3 Marijuana Stocks For Today Watchlist
Neutral
Market Watch
4 weeks ago
Gaetz as Trump's AG seen as bullish for pot stocks, but confirmation looks unlikely
If controversial Republican Matt Gaetz manages to win confirmation as attorney general, his tenure at the Justice Department is expected to be positive for the cannabis industry.
Gaetz as Trump's AG seen as bullish for pot stocks, but confirmation looks unlikely
Neutral
See It Market
1 month ago
Did Cannabis Stocks Finally Bottom?
This story came out today about Trump's potential policy on cannabis.  The statement by Chris Christie: When I was asked about the election, I talked about 3 commonalities among both candidates.
Did Cannabis Stocks Finally Bottom?
Negative
Market Watch
1 month ago
Cannabis stock valuations and investments hobbled by regulatory uncertainties, experts say
A reality check around regulatory challenges facing the cannabis sector has taken hold among some of the leading financiers in the industry, as optimism around the promise of a legal market has faded.
Cannabis stock valuations and investments hobbled by regulatory uncertainties, experts say
Positive
Seeking Alpha
1 month ago
Aurora Cannabis: Buy The Election Overreaction
Aurora Cannabis dropped over 10%, along with the broader cannabis market, due to concerns over U.S. election results. Despite this, Aurora has no U.S. cannabis operations and is unaffected. Aurora reported robust revenue growth, with a 29% YoY increase, driven by a 93% rise in international medical cannabis sales. The company re-affirmed positive free cash flow expectations for Q3 and demonstrated strong spending discipline, maintaining positive adjusted EBITDA for the 8th consecutive quarter.
Aurora Cannabis: Buy The Election Overreaction
Charts implemented using Lightweight Charts™